THEOLYTICS
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
THEOLYTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-12-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.theolytics.com
Total Employee:
11+
Status:
Active
Total Funding:
10.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Microsoft Azure DNS Google Google Cloud
Similar Organizations
Agathos Biologics
Agathos Biologics is a biotechnology company developing transformational science within a strong ethical and moral framework.
AI4R
AI4R engages in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Apoglyx
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Carcell Biopharma
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Engimmune Therapeutics
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
eureKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
FimmCyte
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
GeneMedicine
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
HEPHAISTOS-Pharma
HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies.
Innatera Nanosystems
Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
Innoskel
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Mediar Therapeutics
Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis.
NAVAN Technologies
NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies
Olgram
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Opal Biosciences
Opal Biosciences is a preclinical-stage biotechnology company specializing in treating infectious diseases.
PamBio
PamBio is a pre-clinical stage biotechnology company developing drug therapy for acute bleeding conditions.
PEP-Therapy
Innovative peptides as targeted therapies for oncology
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Saftra Photonics
Saftra Photonics is a Slovak high-tech company established as a spin-off from the P. J. Safarik University, Kosice, Slovakia in 2014.
TandemAI
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Unibio
Unibio provides sustainable protein services for the biotechnology sector.
Current Advisors List
Board_member
2019-06-01
Board_member
2021-01-07
Board_member
2020-01-01
Board_member
2021-01-07
Advisor
2017-01-01
Advisor
2017-01-01
Current Employees Featured
Charlotte Casebourne CEO @ Theolytics
CEO
2017-12-01
Margaret Duffy CSO @ Theolytics
CSO
2017-12-01
Kerry Fisher President of Research @ Theolytics
President of Research
2017-01-01
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Theolytics
Epidarex Capital
Epidarex Capital investment in Series A - Theolytics
Taiho Ventures
Taiho Ventures investment in Series A - Theolytics
M Ventures
M Ventures investment in Series A - Theolytics
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Theolytics
Official Site Inspections
http://www.theolytics.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.29 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Theolytics"
Theolytics | Biotech | England
Theolytics is a biotech company working to transform patients’ lives, through world leading science, with a great team. Everyone should have access to innovative therapies that …See details»
Theolytics - Crunchbase Company Profile & Funding
Theolytics is a clinical stage biotechnology company harnessing viruses to combat disease. A step-change in the adenoviral therapy field, our phenotypic …See details»
Team - Theolytics
Our team is one of the most important elements of who we are and what we do. We combine world leading scientific expertise – spanning virology, cancer biology, immunology, …See details»
Theolytics 2025 Company Profile: Valuation, Funding
Theolytics General Information Description. Operator of the phenotypic screening platform intended to harness viruses to combat cancer. The company focuses …See details»
Technology - Theolytics
At Theolytics we are focused on harnessing viruses to combat disease. Our discovery platforms leverage systematic phenotypic screening technologies to power the discovery of therapies …See details»
Member profile: Theolytics Ltd | BIA - bioindustry.org
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. The company was formed in 2017 to drive the development of a pipeline of …See details»
Theolytics Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Theolytics, a clinical biotech firm, is pioneering the use of viruses to fight diseases. As a game-changer in adenoviral therapy, their phenotypic screening platform facilitates the identification …See details»
Theolytics - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Theolytics - Contacts, Employees, Board Members, Advisors
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.See details»
Theolytics - VentureRadar
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. The company was formed in 2017 to drive the development of a pipeline of …See details»
Theolytics - Oxford Science Enterprises
Theolytics is a pre-clinical biotech company harnessing oncolytics viruses to treat cancers, utilising systematic phenotypic screening and selection systems optimised for translational success. What Life Sciences. When Dec 2017. …See details»
Theolytics - LinkedIn
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and ...See details»
Theolytics Company Profile - Office Locations, Competitors, …
Theolytics has 5 employees at their 1 location and $6.8 m in total funding,. See insights on Theolytics including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Theolytics’ Innovative Approach to Cancer: Oncolytic Viruses and …
Feb 12, 2025 Theolytics, a spinout supported by Oxford University Innovation, is leading the way in this cutting-edge cancer treatment by harnessing the power of oncolytic viruses. By …See details»
Theolytics - Overview, News & Similar companies | ZoomInfo.com
Apr 1, 2024 Sound Bioventures joins £19M ($24.5M) financing in UK oncolytic virus company Theolytics Stockholm, Sweden and Washington D.C., USA – 17 April 2024 - Sound …See details»
News - Theolytics
Dec 17, 2024 Theolytics presents data at ESMO on its lead program being developed for Ovarian Cancer. Jun 9, 2023. Theolytics presents data on THEO-260 and THEO-310 at ASCO …See details»
Theolytics raises $6.8m Series A round funding - The Oxford …
Jan 8, 2021 Theolytics, which was founded in 2017 and is headquartered in Oxford, UK, is backed by Oxford Sciences Innovation (OSI) and international life sciences investors Epidarex …See details»
Theolytics presents CAF-targeting therapy for stromal rich …
Oct 6, 2022 Theolytics, which was founded in 2017 and is headquartered in Oxford, UK, backed by OxSciences and international life sciences investors Epidarex Capital, Taiho Ventures, and …See details»
Theolytics Appoints David Apelian MD, PhD, MBA as CEO
Dec 17, 2024 David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology joins Theolytics Dr Apelian joins …See details»
What is Theolytics? Company Culture, Mission, Values
See what employees say it's like to work at Theolytics. Salaries, reviews, and more - all posted by employees working at Theolytics.See details»